Skip to content
Clinical Trial Events
SCOPE Europe 2026

Talk Patient Engagement and Recruitment track

How AI Feasibility and Pre-Screening at the Point of Care Increases Enrollment at Cancer Centers

Wed, Oct 14, 2026 · 1:55–2:20 PM CEST InterContinental Barcelona

About this session

Sponsored by Triomics. AI is transforming oncology trial enrollment by enabling faster, more accurate feasibility assessments and automated patient pre-screening at the point of care. This session explores how leading cancer centers are leveraging AI and EHR data to identify eligible patients, reduce manual screening burdens, streamline research workflows, and improve enrollment efficiency, ultimately expanding patient access to clinical trials.

Speaker

Reviews of this session

No reviews yet

Were you in the room? Reviews are open until Oct 14, 2027.

Write the first review